The city issued a permit Sept. 22 for Dav-Lin Inc. to renovate a Gate Parkway building for the U.S. corporate headquarters for Italy-based Medical Microinstruments Inc.
The robotics company focuses on microsurgery.
Dav-Lin will renovate 17,606 square feet of space within Building 500 at 5022 Gate Parkway at a project cost of almost $1.2 million. Connie Turner Interiors Inc. is the interior designer and space planner.
The project includes the headquarters along with storage and distribution space for medical robots.
Plans indicate offices for the CEO and CFO, other office space, conference rooms, a demonstration area and a robotics storage area.
The building is in Meridian Business Park, which is owned by Taurus Investment Holdings LLC.
Property records show the 31,250-square-foot Building 500 was built in 2003.
The Cushman & Wakefield real estate company said in its second-quarter Jacksonville office report that Medical Instruments Inc. has leased 31,000 square feet at 5022 Gate Parkway, No. 500.
MMI said Medical Microinstruments SpA was founded in 2015 near Pisa, Italy, to enhance surgical performance through the development of a robotic system that enables surgeons to achieve better outcomes in microsurgery.
MMImicro.com shows it has headquarters in Pisa and U.S. offices in Wilmington, Delaware.
Its news releases have been datelined Jacksonville since at least Jan. 4, 2023, indicating the headquarters decision was determined months ago.
The company developed the Symani Surgical System, which it says is developed specifically to address the challenges of microsurgery.
“Symani is the only system that offers wristed microinstruments designed to improve a surgeon’s ability to access and suture small, delicate anatomy,” says mmimicro.com.
“The platform provides motion scaling and tremor reduction to allow the surgeon to perform precise micro-movements.”
It says the proprietary NanoWrist microinstruments add the needed dexterity to access and suture hard-to-reach anatomy.
In a March 23, 2023, news release, MMI said the Symani System is CE Marked and commercially available in Europe.
The system is not approved or cleared for commercial use in the United States, the release said.
MMI said it is backed by international medtech investors including Andera Partners, BioStar, Deerfield Management, Fountain Healthcare Partners, Panakès Partners, RA Capital, Sambatech and Wellington Partners.
MMI said it was named to Fast Company’s annual list of the World’s Most Innovative Companies for 2023, earning the No. 2 spot in the Medical Devices category.